The Monetary Value of a Statistical Life in the Context of Atherosclerotic Cardiovascular Disease
PharmacoEconomics · 2025
DOI: 10.1007/s40273-025-01482-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift PharmacoEconomics, 2025. Verfasst von Jorge-Eduardo Martínez-Pérez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Economics, Faculty of Economics and Business, University of Murcia, Campus de Espinardo, Edificio no. 2, 30100, Murcia, Spain. …. Hauptthemen laut MEDLINE: Atherosclerosis, Value of Life, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Estatal de Investigación, Novartis Farmacéutica, Universidad de Murcia.
Abstract (Originalsprache)
AIM: This study aims to estimate the value of a statistical life (VSL) in the context of atherosclerotic cardiovascular disease (ASCVD) in Spain using a contingent valuation/standard gamble (CV/SG) chained approach. METHODS: The study employed a two-stage preference elicitation method that combined contingent valuation and a modified standard gamble technique. Specifically, willingness-to-pay and willingness-to-accept values were obtained for two health states depicting hypothetical outcomes following cardiovascular events. Subsequently, relative utility losses for the health states were derived using a modified standard gamble framing two risky choices. Chaining these elicited values allowed for VSL calculation without requiring direct valuation of small mortality risk reductions. The study was conducted through in-person interviews with a representative sample of 412 Spanish adults selected by stratified quotas. RESULTS: The estimated VSL range is from 1.59 to 2.06 million euros. Minor differences emerge between VSL figures on the basis of each of the two health states. These VSL estimates for ASCVD are congruent with the recent update of the official VSL estimated for Spain in the context of road traffic accidents, though the upper limit of the range is slightly higher (almost 9%). CONCLUSIONS: VSL estimates align with existing ranges in other European countries, particularly in the context of road safety, where a significant portion of existing studies is concentrated. Comparisons with other contexts, involving cardiovascular diseases, also lend support to the estimates presented here.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Applied Economics, Faculty of Economics and Business, University of Murcia, Campus de Espinardo, Edificio no. 2, 30100, Murcia, Spain. jorgemp@um.es.
- Department of Applied Economics, Faculty of Economics and Business, University of Murcia, Campus de Espinardo, Edificio no. 2, 30100, Murcia, Spain.
- Hospital Virgen de la Arrixaca, Centro Nacional de Investigaciones Cardiovasculares (CNIC), University of Murcia, Murcia, Spain.
ORCID-Profile: Jorge-Eduardo Martínez-Pérez, Fernando-Ignacio Sánchez-Martínez, José-María Abellán-Perpiñán, Domingo Pascual-Figal
Förderung
- Agencia Estatal de Investigación
- Novartis Farmacéutica
- Universidad de Murcia
Zitieren
APA
Martínez-Pérez, J. E., Sánchez-Martínez, F. I., Abellán-Perpiñán, J. M., & Pascual-Figal, D. (2025). The Monetary Value of a Statistical Life in the Context of Atherosclerotic Cardiovascular Disease. PharmacoEconomics. https://doi.org/10.1007/s40273-025-01482-3
Vancouver
Martínez-Pérez JE, Sánchez-Martínez FI, Abellán-Perpiñán JM, Pascual-Figal D. The Monetary Value of a Statistical Life in the Context of Atherosclerotic Cardiovascular Disease. PharmacoEconomics. 2025. doi:10.1007/s40273-025-01482-3
BibTeX
@article{MartnezPrez2025,
author = {Martínez-Pérez, Jorge-Eduardo and Sánchez-Martínez, Fernando-Ignacio and Abellán-Perpiñán, José-María and Pascual-Figal, Domingo},
title = {The Monetary Value of a Statistical Life in the Context of Atherosclerotic Cardiovascular Disease},
journal = {PharmacoEconomics},
year = {2025},
doi = {10.1007/s40273-025-01482-3}
}
EUVIMED